CN113684151B - 表皮葡萄球菌及其发酵培养和应用 - Google Patents
表皮葡萄球菌及其发酵培养和应用 Download PDFInfo
- Publication number
- CN113684151B CN113684151B CN202110980016.3A CN202110980016A CN113684151B CN 113684151 B CN113684151 B CN 113684151B CN 202110980016 A CN202110980016 A CN 202110980016A CN 113684151 B CN113684151 B CN 113684151B
- Authority
- CN
- China
- Prior art keywords
- staphylococcus epidermidis
- staphylococcus
- fermentation
- skin
- fermentation culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000191963 Staphylococcus epidermidis Species 0.000 title claims abstract description 44
- 238000000855 fermentation Methods 0.000 title claims abstract description 36
- 230000004151 fermentation Effects 0.000 title claims abstract description 36
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 27
- 239000002207 metabolite Substances 0.000 claims abstract description 17
- 230000037307 sensitive skin Effects 0.000 claims abstract description 14
- 244000005700 microbiome Species 0.000 claims abstract description 11
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 8
- 239000006228 supernatant Substances 0.000 claims description 32
- 239000002609 medium Substances 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000012136 culture method Methods 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 241000295644 Staphylococcaceae Species 0.000 abstract description 7
- 230000000813 microbial effect Effects 0.000 abstract description 6
- 230000035755 proliferation Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000004321 preservation Methods 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 241000191940 Staphylococcus Species 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 230000012010 growth Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229910052714 tellurium Inorganic materials 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- SITVSCPRJNYAGV-UHFFFAOYSA-L tellurite Chemical compound [O-][Te]([O-])=O SITVSCPRJNYAGV-UHFFFAOYSA-L 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- -1 tellurium ions Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
菌种 | 菌株数 | |
1 | 表皮葡萄球菌 | 17株 |
2 | 迟缓葡萄球菌 | 3株 |
3 | 松鼠葡萄球菌 | 2株 |
4 | 中间葡萄球菌 | 1株 |
5 | 葡萄球菌.SP | 3株 |
6 | 微球菌 | 2株 |
取样时间点 | 上清的抑菌时间 |
4h | 0h |
8h | 0h |
12h | 小于2h |
16h | 8h |
24h | 8-10h |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110980016.3A CN113684151B (zh) | 2021-08-25 | 2021-08-25 | 表皮葡萄球菌及其发酵培养和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110980016.3A CN113684151B (zh) | 2021-08-25 | 2021-08-25 | 表皮葡萄球菌及其发酵培养和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113684151A CN113684151A (zh) | 2021-11-23 |
CN113684151B true CN113684151B (zh) | 2023-05-23 |
Family
ID=78582321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110980016.3A Active CN113684151B (zh) | 2021-08-25 | 2021-08-25 | 表皮葡萄球菌及其发酵培养和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113684151B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114058559B (zh) * | 2022-01-17 | 2022-04-08 | 山东锦鲤生物工程有限公司 | 表皮葡萄球菌及其应用 |
CN114574427B (zh) * | 2022-01-27 | 2022-10-14 | 唐颐华臻检测技术(北京)有限公司 | 一种基于金黄色葡萄球菌的皮肤炎症体外评价模型的构建方法、评价模型及其应用 |
CN115919734B (zh) * | 2022-12-29 | 2023-07-14 | 山东福瑞达生物股份有限公司 | 一种共培养表皮葡萄球菌发酵液及其应用 |
CN116286543B (zh) * | 2023-04-14 | 2023-07-21 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 具有良好保湿美白抗炎抗氧化抗衰老功效的表皮葡萄球菌及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745501B (zh) * | 2013-12-31 | 2019-12-20 | 中粮营养健康研究院有限公司 | 一种表皮葡萄球菌及其应用 |
CN108753646B (zh) * | 2018-06-12 | 2021-10-22 | 上海交通大学医学院附属仁济医院 | 一株对革兰阳性耐药菌具有广谱抗菌活性的人葡萄球菌及其筛选方法和应用 |
CN108823124B (zh) * | 2018-06-12 | 2021-10-22 | 上海交通大学医学院附属仁济医院 | 一株对革兰阳性耐药菌具有广谱抗菌活性的表皮葡萄球菌及其筛选方法和应用 |
CN111763630A (zh) * | 2019-03-27 | 2020-10-13 | 深圳微健康基因科技有限公司 | 表皮葡萄球菌及其用途 |
CN110184224B (zh) * | 2019-06-18 | 2020-08-25 | 上海交通大学 | 一株表皮葡萄球菌及其应用 |
-
2021
- 2021-08-25 CN CN202110980016.3A patent/CN113684151B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113684151A (zh) | 2021-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113684151B (zh) | 表皮葡萄球菌及其发酵培养和应用 | |
Rotimi et al. | Activities of Nigerian chewing stick extracts against Bacteroides gingivalis and Bacteroides melaninogenicus | |
Fields et al. | Intracellular multiplication of Legionella pneumophila in amoebae isolated from hospital hot water tanks | |
CN108486022A (zh) | 一株抗龋病植物乳杆菌及其应用 | |
CN107828665B (zh) | 一种竹叶兰内生真菌的分离纯化方法及其应用 | |
CN114276958B (zh) | 具有抗炎功效的三重益生菌发酵复合物的制备方法和应用 | |
CN108949618B (zh) | 一种溶藻细菌及其应用 | |
CN112501090B (zh) | 一株地衣芽孢杆菌及其应用 | |
CN104946574B (zh) | 一株抑制植物病原真菌的枯草芽孢杆菌Baisha2C | |
CN115181695B (zh) | 一种植物乳杆菌5b4m2及其应用 | |
CN116515666A (zh) | 一株具有治疗痤疮作用的瑞士乳杆菌及其应用 | |
CN109652482B (zh) | 一种抗菌肽及其制备方法与应用 | |
CN107034167A (zh) | 一种防治猕猴桃溃疡病的赖氨酸芽孢杆菌及其应用 | |
CN109022303B (zh) | 一种具有溶藻和破坏微藻气囊的功能的组合物及其应用 | |
CN116694535A (zh) | 一种戊糖乳杆菌w19及其应用 | |
CN113897309B (zh) | 一种具有广谱杀藻活性的海洋微泡菌及其应用 | |
CN109810918B (zh) | 一株对枸杞叶枯病有防效的萎缩芽孢杆菌、生物菌剂及其应用 | |
CN106377802A (zh) | 一种含有乳酸菌的发酵上清的人体润滑剂 | |
Serfontein et al. | The isolation and characterisation of Xylophilus ampelinus | |
CN114317617B (zh) | 具有抗皱功效的三重益生菌发酵复合物制备方法及其应用 | |
CN115181698B (zh) | 一种益生菌组合物及应用 | |
CN113528406B (zh) | 一种短短芽孢杆菌adt及其应用 | |
KR102492106B1 (ko) | 화장료 조성물 | |
CN116640704B (zh) | 一株抑制幽门螺旋杆菌的戊糖片球菌及其应用 | |
CN111808785B (zh) | 红花龙胆内生贝莱斯芽孢杆菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 201500 building 6, No. 857, Tiangong Road, Jinshan District, Shanghai Applicant after: Shanghai Jiakai Biological Co.,Ltd. Address before: 201500 building 6, No. 857, Tiangong Road, Jinshan District, Shanghai Applicant before: SHANGHAI JIAKAI BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 818 Tiangong Road, Jinshan District, Shanghai, 200540 Patentee after: Shanghai Jiakai Biological Co.,Ltd. Address before: 201500 building 6, No. 857, Tiangong Road, Jinshan District, Shanghai Patentee before: Shanghai Jiakai Biological Co.,Ltd. |